140 related articles for article (PubMed ID: 9477131)
1. Development of a "Myeloma Risk Score" using a population-based registry on paraproteinemia and myeloma.
Ong F; Hermans J; Noordijk EM; De Kieviet W; Seelen PJ; Wijermans PW; Kluin-Nelemans JC
Leuk Lymphoma; 1997 Nov; 27(5-6):495-501. PubMed ID: 9477131
[TBL] [Abstract][Full Text] [Related]
2. Serum neural cell adhesion molecule differentiates multiple myeloma from paraproteinemias due to other causes.
Ong F; Kaiser U; Seelen PJ; Hermans J; Wijermans PW; de Kieviet W; Jaques G; Kluin-Nelemans JC
Blood; 1996 Jan; 87(2):712-6. PubMed ID: 8555495
[TBL] [Abstract][Full Text] [Related]
3. A case of IgD myeloma representing a missed biclonal paraproteinemia or isotype switch in a patient previously diagnosed with IgA-lambda myeloma.
Chepovetsky J; Chari A; Jagannath S; Ramanthan L
Clin Chim Acta; 2013 Oct; 425():233-5. PubMed ID: 23954772
[TBL] [Abstract][Full Text] [Related]
4. Are serum interleukin-6 levels always useful for differentiating monoclonal gammopathies in unselected patients?
Greco C; Vitelli G; Cianciulli AM; Alvino S; Gandolfo GM; Ameglio F
Blood; 1992 Apr; 79(8):2173-4. PubMed ID: 1562744
[No Abstract] [Full Text] [Related]
5. Immunochemical and clinical characteristic of series of 516 paraproteinemic patients.
Tichý M; Hrncir Z; Mracek J; Hrncirová L; Matĕja F
Neoplasma; 1978; 25(4):477-81. PubMed ID: 99675
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD56 (NCAM): a new differential-diagnostic and prognostic marker in multiple myeloma.
Kaiser U; Oldenburg M; Jaques G; Auerbach B; Havemann K
Ann Hematol; 1996 Sep; 73(3):121-6. PubMed ID: 8841099
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal gammopathy of unknown significance and malignant paraproteinemia in Hong Kong.
Lolin YI; Chow J; Wickham NW
Am J Clin Pathol; 1996 Oct; 106(4):449-56. PubMed ID: 8853031
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
Lakomy D; Lemaire-Ewing S; Denimal D; Bastie JN; Lafon I; Caillot D
Ann Biol Clin (Paris); 2013; 71(2):157-63. PubMed ID: 23587579
[TBL] [Abstract][Full Text] [Related]
9. The value of the bone marrow plasma cell cytoplasmic light chain ratio in differentiating between multiple myeloma and monoclonal gammopathy of undetermined significance.
Majumdar G; Grace RJ; Singh AK; Slater NG
Leuk Lymphoma; 1992 Dec; 8(6):491-3. PubMed ID: 1297481
[TBL] [Abstract][Full Text] [Related]
10. Myeloma with two monoclonal IgG and IgD in serum: a case report.
Franck P; Petitpain N; Guerci AP; Denisart S; Jacob C; Guéant JL
Acta Haematol; 1994; 92(3):144-7. PubMed ID: 7871954
[TBL] [Abstract][Full Text] [Related]
11. IgD paraproteinemias.
Tichý M; Matĕja F; Urban P; Matuska M
Neoplasma; 1993; 40(1):59-61. PubMed ID: 8350950
[TBL] [Abstract][Full Text] [Related]
12. [The risk of a multiple myeloma in patients with paraproteinemia: a myeloma risk score developed in the region of the Comprehensive Cancer Center West].
Schaar CG; Ong F; Snijder S; Wijermans PW; Franck PF; Kluin-Nelemans JC
Ned Tijdschr Geneeskd; 1998 Jul; 142(28):1591-5. PubMed ID: 9763839
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous production of IgG lambda and IgA lambda in a clone of myeloma cells.
Maruyama Y; Sakamaki H; Yahara Y; Onozawa Y; Ozawa N; Shimizu M; Hayashi Y; Kawaguchi K
Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):86-92. PubMed ID: 2500824
[TBL] [Abstract][Full Text] [Related]
14. Is the Durie and Salmon diagnostic classification system for plasma cell dyscrasias still the best choice? Application of three classification systems to a large population-based registry of paraproteinemia and multiple myeloma.
Ong F; Hermans J; Noordijk EM; Kluin-Nelemans JC
Ann Hematol; 1995 Jan; 70(1):19-24. PubMed ID: 7827202
[TBL] [Abstract][Full Text] [Related]
15. Subclasses IgG1--IgG4 in 84 sera with IgG paraprotein.
Tichý M; Hrncír Z; Mracek J
Neoplasma; 1978; 25(1):107-10. PubMed ID: 634402
[TBL] [Abstract][Full Text] [Related]
16. Developing a population-based registry for patients with paraproteinemias or multiple myeloma.
Ong F; Hermans J; Noordijk EM; de Kieviet W; Wijermans PW; Seelen PJ; Snijder S; Oostindiër MJ; Kluin-Nelemans JC
J Clin Epidemiol; 1997 Aug; 50(8):909-15. PubMed ID: 9291876
[TBL] [Abstract][Full Text] [Related]
17. Plasma cell dyscrasia. Analysis of 423 patients.
Pick AI; Shoenfeld Y; Frohlichmann R; Weiss H; Vana D; Schreibman S
JAMA; 1979 May; 241(21):2275-8. PubMed ID: 108408
[TBL] [Abstract][Full Text] [Related]
18. The search for meaning in monoclonal protein. Is it multiple myeloma or monoclonal gammopathy of undetermined significance?
Brigden ML
Postgrad Med; 1999 Aug; 106(2):135-42; quiz 185. PubMed ID: 10456045
[TBL] [Abstract][Full Text] [Related]
19. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic criteria of multiple myeloma.
Kyle RA
Hematol Oncol Clin North Am; 1992 Apr; 6(2):347-58. PubMed ID: 1582977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
